Global pharmaceutical company Cipla Ltd, has appointed Peter Lankau as an independent director on its board with effect from January 10.
Lankau has graduated with Bachelors of Science in Biology from the State University of New York at Albany, USA.
He has over 30 years of management experience in developing and commercialising pharmaceutical products.
Lankau is currently a principal of Lankau Consulting LLC.
He was previously Executive Chairman of the Board for Nautilus Neurosciences, Inc., Chairman & CEO of Logical Therapeutics, Inc and President & CEO of Endo Pharmaceuticals Inc.